Sign in

    Philip Morris International Inc (PM)

    You might also like

    Philip Morris International Inc. (PMI) is a leading international tobacco company committed to creating a smoke-free future by expanding its portfolio beyond traditional tobacco and nicotine products. The company primarily sells cigarettes and smoke-free products, which include heat-not-burn, e-vapor, and oral nicotine products, as well as wellness and healthcare products through its Vectura Fertin Pharma business . PMI has invested significantly in developing innovative smoke-free products, with brands like IQOS and ZYN leading their smoke-free portfolio . The company's operations are organized into several geographical segments, focusing on different regions worldwide .

    1. Smoke-Free Products - Includes heat-not-burn, e-vapor, and oral nicotine products, with leading brands such as IQOS and ZYN driving the company's transition to a smoke-free future.
      • IQOS - A heat-not-burn product designed to provide a smoke-free alternative to traditional cigarettes.
      • ZYN - An oral nicotine product offering a smoke-free experience.
    2. Wellness and Healthcare - Focuses on inhaled therapeutics and oral delivery systems through the Vectura Fertin Pharma business, expanding PMI's reach beyond traditional tobacco products.
    3. Combustible Tobacco Products - Comprises traditional cigarettes and other tobacco products, continuing to contribute to the company's revenue.
    4. Geographical Segments - Organized into Europe, South and Southeast Asia, Commonwealth of Independent States, Middle East and Africa (SSEA, CIS & MEA), East Asia, Australia, and PMI Duty Free (EA, AU & PMI DF), and the Americas, allowing PMI to cater to diverse markets worldwide.
    NamePositionExternal RolesShort Bio

    André Calantzopoulos

    ExecutiveBoard

    Executive Chairman

    None

    André Calantzopoulos has been with PM since 1985, serving as CEO from 2013 to 2021. He became Executive Chairman in May 2021.

    Emmanuel Babeau

    Executive

    Chief Financial Officer

    Board member of Davide Campari-Milano N.V.

    Emmanuel Babeau joined PM as CFO in May 2020. He oversees financial operations and compliance, with prior experience at Schneider Electric and Pernod Ricard.

    Frederic de Wilde

    Executive

    President, South and Southeast Asia, CIS, Middle East and Africa Region

    None

    Frederic de Wilde joined PM in 1992 and has held various roles, including President of the European Union Region. He became President of his current region in January 2023.

    Jacek Olczak

    Executive

    Chief Executive Officer

    None

    Jacek Olczak has been the CEO since May 2021, having joined PM in 1993. He has held various roles, including COO and CFO, and played a pivotal role in PM's transformation and growth of reduced-risk products.

    Lars Dahlgren

    Executive

    President, Smoke-Free Oral Products & CEO of Swedish Match

    None

    Lars Dahlgren joined PM following its acquisition of Swedish Match, where he was CEO. He has been President, Smoke-Free Oral Products & CEO of Swedish Match since January 2023.

    Reginaldo Dobrowolski

    Executive

    Vice President and Controller

    None

    Reginaldo Dobrowolski has held various finance roles at PM and became Vice President and Controller in August 2021.

    Stacey Kennedy

    Executive

    President, Americas Region & CEO of PMI's U.S. Business

    None

    Stacey Kennedy joined PM in 1995 and has held various roles, including President of South and Southeast Asia Region. She became President, Americas Region & CEO of PMI's U.S. Business in January 2023.

    Stefano Volpetti

    Executive

    President, Smoke-Free Inhalable Products & Chief Consumer Officer

    None

    Stefano Volpetti joined PM in 2019 and has led smoke-free transformation efforts. He became President, Smoke-Free Inhalable Products & Chief Consumer Officer in January 2023.

    Vassilis Gkatzelis

    Executive

    President, East Asia, Australia, and PMI Duty Free Region

    None

    Vassilis Gkatzelis joined PM in 2003 and has held various roles in marketing and management. He became President of his current region in May 2024.

    Werner Barth

    Executive

    President, Combustibles Category & Global Combustibles Marketing

    None

    Werner Barth joined PM in 1990 and has held various marketing and commercial roles. He became President of Combustibles Category & Global Combustibles Marketing in November 2021.

    Yann Guérin

    Executive

    Senior Vice President and General Counsel

    None

    Yann Guérin joined PM in 2006 and has held various legal roles. He became Senior Vice President and General Counsel in July 2023.

    Juan José Daboub

    Board

    Director

    Chairman, President, and CEO of The Daboub Partnership of Arcis, LLC; Vice Chairman of Dorado Partners LLC; President of the HUGE Business and Investment Council

    Juan José Daboub has been a director at PM since 2021, with expertise in governance and sustainability.

    Kalpana Morparia

    Board

    Director

    Board member of HSBC Holdings plc, Dr. Reddy’s Laboratories Ltd., and Hindustan Unilever Limited

    Kalpana Morparia has been a director at PM since 2011, with strong leadership experience in finance and international business.

    Lisa A. Hook

    Board

    Lead Independent Director

    Board member of Fidelity National Information Services, Inc. and Nokia Corporation

    Lisa A. Hook has been a director at PM since 2018 and became Lead Independent Director in May 2023. She has extensive experience in telecommunications and digital transformation.

    Robert B. Polet

    Board

    Director

    Chairman of SFMS B.V. and Arica Holding B.V.; Board Member of Safilo Group S.p.A.

    Robert B. Polet has been a director at PM since 2011, bringing experience in global luxury brands and consumer goods.

    1. One of your peers highlighted that in Europe, vapor is seeing greater success in fully converting smokers than heated tobacco; what are your latest thoughts on this topic, and are you seeing an acceleration in vapor adoption as you roll out VEEV in several markets?

    2. Regarding the illicit nicotine pouches entering the U.S. market that may infringe on your patents, could you expand on what measures you are currently taking or expect to take, and how do you think this will differ from the current environment we see in vapor in the U.S.?

    3. Considering your increased pricing guidance of 8% to 9% and yet positive volumes in combustible cigarettes, shouldn't FY '25 also be a strong year for cigarette volumes and pricing internationally, and can you touch on any disruptive excise tax hikes expected in the next few months?

    4. It looks like you modestly took down the top end of your potential deleveraging for this year; could you address what drove that, and with sizable maturities over 2025, are you considering pulling some of that refinancing forward into the remainder of this year, given where markets are opportunistically?

    5. With the ongoing supply constraints for ZYN in the U.S., what measures are you taking to match consumer demand, and how confident are you in your capacity expansion plans to meet future growth?

    Program DetailsProgram 1
    Approval DateJune 11, 2021
    End Date/DurationJuly 21, 2024
    Total additional amount$7 billion
    Remaining authorization$6,016,847,275
    DetailsProgram suspended on May 11, 2022, due to the acquisition of Swedish Match. No repurchases in 2023 and 2024.
    YearAmount Due (in millions)Debt TypeInterest Rate (%)% of Total Debt
    2024$4,833 Current portion of long-term debtN/A9.8% = (4,833 / 49,200) * 100
    2024$299 Swiss franc note1.625 0.6% = (299 / 49,200) * 100
    2025$3,000 Euro credit facility borrowings4.009 (average) 6.1% = (3,000 / 49,200) * 100
    2027$2,500 Euro credit facility borrowings4.009 (average) 5.1% = (2,500 / 49,200) * 100
    2027$6,140 Euro credit facility borrowings (Swedish Match acquisition)4.009 (average) 12.5% = (6,140 / 49,200) * 100
    2029$236 Swedish krona notes1.395 to 2.710 (avg 2.016) 0.5% = (236 / 49,200) * 100
    2032$486 Other (includes bank loans and finance leases)5.038 (average) 1.0% = (486 / 49,200) * 100
    2039$8,126 Euro notes0.125 to 3.750 (avg 1.964) 16.5% = (8,126 / 49,200) * 100
    2044$34,082 U.S. dollar notes0.875 to 6.375 (avg 4.572) 69.3% = (34,082 / 49,200) * 100

    Competitors mentioned in the company's latest 10K filing.

    CompanyDescription

    A competitor in the tobacco industry, which includes both traditional and innovative products. The company ended its commercial relationship with this competitor in the U.S. covering IQOS as of April 30, 2024.

    A competitor in the tobacco industry, competing in both traditional and innovative product categories.

    Japan Tobacco Inc.

    A competitor in the tobacco industry, operating in both traditional and innovative product categories.

    Imperial Brands plc

    A competitor in the tobacco industry, competing in both traditional and innovative product categories.

    Swedish Match AB

    Acquired by the company in November 2022, this competitor was a leader in oral nicotine delivery with its ZYN brand. The acquisition has been a key milestone in the company's transformation to becoming a smoke-free company.

    State-owned tobacco enterprises

    Competitors in various countries, including Algeria, Egypt, China, Taiwan, Thailand, and Vietnam, which may have different regulatory and market dynamics.

    New market entrants

    Competitors in the non-combustible product category, which may alienate consumers through inappropriate marketing campaigns, messaging, and inferior product satisfaction.

    CustomerRelationshipSegmentDetails

    Europe Region Distributor

    Distributor

    Europe

    Accounted for 12% in 2023 , 13% in 2022 , and 13% in 2021 of consolidated net revenues.

    EA, AU & PMI DF Region Distributor

    Distributor

    East Asia, Australia & PMI Duty Free

    Accounted for 11% in 2023 , 12% in 2022 , and 15% in 2021 of consolidated net revenues.

    NameStart DateEnd DateReason for Change
    PricewaterhouseCoopers SA2008 PresentCurrent auditor

    Notable M&A activity and strategic investments in the past 3 years.

    CompanyYearDetails

    United Tobacco Company (UTC)

    2024

    PMI acquired a controlling interest of 54.25% in UTC via an incremental purchase priced at a total of $315 million (including cash, contingent consideration, and assumed loans), with a fair value allocation of $655 million that supports manufacturing synergies in Egypt.

    Eastern Company

    2024

    PMI acquired an indirect 14.7% economic interest in Eastern Company, Egypt’s largest cigarette manufacturer, and later guaranteed up to $385 million in credit facilities until 2034 to bolster its influence under the equity method.

    Swedish Match AB

    2023

    PMI, through its subsidiary PMHH, completed the 100% acquisition of Swedish Match AB for $883 million by compulsorily redeeming the remaining shares, thereby advancing its transformation into a smoke‑free company through an enhanced portfolio in oral nicotine products.

    Philip Morris Tütün Mamulleri Sanayi ve Ticaret A.Ş.

    2022

    PMI acquired the remaining 25% stake (along with a 24.75% stake in the related subsidiary) from Sabanci Holding for approximately $223 million, consolidating full ownership and adjusting its capital structure.

    Philip Morris Pazarlama ve Satış A.Ş.

    2022

    PMI acquired the remaining 24.75% stake for approximately $223 million, resulting in a $30 million decrease in additional paid-in capital and a $171 million increase in accumulated other comprehensive losses from reclassified currency translation losses.

    Recent developments and announcements about PM.

    Earnings

    • New Earnings (Q4 2024)

      ·
      Feb 6, 2025, 6:07 PM

      Philip Morris expects robust 2025 margin expansion, driven by high-margin smoke-free growth (ZYN, IQOS) and cost efficiencies. With 20% of HTU potential still unrealized, mid-2025 US IQOS ILUMA launch could further boost earnings, targeting net profitability in 2–3 years.

      View full earnings summary →

    8-K Filings

    • 8-K Filing

      ·
      Feb 19, 2025, 9:34 PM
      Financial Exhibits
      Regulation FD Disclosure

      On March 7, 2025, a court approved a compromise plan for Philip Morris International’s deconsolidated Canadian affiliate, RBH. The plan settles litigation with a global aggregate of CAD 32.5B, with RBH retaining CAD 750M in cash reserves.

      View full 8-K filing →